Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses

Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infection. Surveillance for oseltamivir resistance is routinely performed to ensure the ongoing efficacy of oseltamivir against circulating viruses. Since the emergence of the pandemic 2009 A(H1N1) influe...

Descripció completa

Dades bibliogràfiques
Autors principals:	Butler, Jeff, Hooper, Kathryn A., Petrie, Stephen, Lee, Raphael, Maurer-Stroh, Sebastian, Reh, Lucia, Guarnaccia, Teagan, Baas, Chantal, Xue, Lumin, Vitesnik, Sophie, Leang, Sook-Kwan, McVernon, Jodie, Kelso, Anne, Barr, Ian G., McCaw, James M., Bloom, Jesse D., Hurt, Aeron C.
Altres autors:	Perez, Daniel R.
Format:	Journal Article
Idioma:	English
Publicat:	2014
Matèries:	DRNTU::Science::Biological sciences::Microbiology::Virology
Accés en línia:	https://hdl.handle.net/10356/101749 http://hdl.handle.net/10220/19748

Internet

https://hdl.handle.net/10356/101749
http://hdl.handle.net/10220/19748

Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses

Internet

Ítems similars